Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...

Some patients are using lower-than-recommended dosages of generic weight-loss drugs to slim down while saving money ...

Q3 2024 Earnings Call Transcript November 4, 2024 Operator: Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

By getting their drugs off the shortage list, Lilly and Novo aim to curtail the market of online pharmacies such as Hims & ...

Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the ...

Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk’s weight-loss and diabetes drugs but cannot ...

Hims Hers Health Inc (NYSE:HIMS) reported third-quarter earnings that surpassed analyst expectations and raised its full-year ...

With the cost of GLP-1s rising for employers, so-called compounded weight-loss drugs have emerged as a more cost-conscious ...

Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2024 in a ...

Incorporating healthy snack foods into your daily routine can help give you energy, satisfy your cravings, and even aid in your weight loss goals ... perk of incorporating cheesy snacks into your meal ...

In addition to a better chance of insurance coverage, compared with online programs, in-person visits allow you to establish a relationship with a professional who can support your weight loss ...